Frank Abenante, MD
Psychiatry · Manahawkin, NJNPI 1730273418
Payments from drug & device makers
Across 706 payments — averaging $113.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45K
- AbbVie$27K
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Bausch Health US, LLC$496
- plus $3K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 105 | $44,825 |
| AbbVie(2 entities) | 112 | $26,667 |
| Neurocrine Biosciences, Inc. | 76 | $2,430 |
| Teva Pharmaceuticals USA, Inc. | 106 | $1,788 |
| Otsuka America Pharmaceutical, Inc. | 79 | $1,168 |
| Bausch Health US, LLC | 34 | $496 |
| Axsome Therapeutics, Inc. | 24 | $409 |
| Supernus Pharmaceuticals, Inc. | 19 | $350 |
| Sunovion Pharmaceuticals Inc. | 21 | $342 |
| Eisai Inc. | 12 | $224 |
| Lundbeck LLC | 13 | $211 |
| Avanir Pharmaceuticals, Inc. | 14 | $185 |
| Vanda Pharmaceuticals Inc. | 13 | $184 |
| Jazz Pharmaceuticals Inc. | 13 | $166 |
| Idorsia Pharmaceuticals US Inc | 9 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $142 |
| Alkermes, Inc. | 8 | $122 |
| Almatica Pharma LLC | 7 | $115 |
| E.r. Squibb & Sons, L.L.C. | 6 | $105 |
| Corium, LLC | 6 | $94 |
| Novo Nordisk | 4 | $62 |
| Neuronetics, Inc. | 4 | $55 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Johnson & Johnson | 2 | $26 |
| Validus Pharmaceuticals LLC | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$80,450 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Manahawkin
- Leon RosenbergCherry Hill$6.4M
- Steven GlassClementon$3.9M
- Judith JosephPaterson$3.8M
- Jeffrey ApterPrinceton$1.7M
- Roberta BallCherry Hill$741K
- Marc CantillonLivingston$524K
- Sanjay VarmaPrinceton$479K
- Manuel SanchezNewark$474K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.